MetaTherapy
Ozempic can quiet a craving. But can it answer what's underneath one? This week's meditation goes somewhere the headlines don't. This is Part 1 of MetaTherapy's three-part Ozempic series — exploring the psychology, neuroscience, and identity questions behind one of the most talked-about drugs of our time. Today, we start with stillness. In this guided meditation, we turn toward craving itself — not to eliminate it, not to judge it, but to get curious about what it's been trying to do for you. We sit with the quiet underneath wanting. And we carry one question into the week. 🕯 WHAT YOU'LL EXPERIENCE • A grounding breath practice to settle the nervous system • A guided inquiry into the body's experience of craving • A therapeutic reframe: craving as information, not failure • Space to sit with what lives underneath the wanting • A carry-home question to hold through the week ⏱ TIMESTAMPS • 0:00 — Introduction: What Ozempic is revealing about the brain • 3:00 — Settling in: Breath and body • 6:00 — Noticing the want • 9:00 — Getting curious: What is craving trying to do? • 12:00 — The quiet underneath • 14:00 — Closing reflection and carry-home question • 17:00 — Outro and series preview 📺 THE OZEMPIC SERIES — THIS WEEK ON METATHERAPY • Monday (today): Meditation — The Quiet That Ozempic Can't Give You • Tuesday: Therapy Tech — What Ozempic Is Actually Doing to Your Brain [link when live] 📚 RESOURCES MENTIONED • Lancet Psychiatry (April 2026) — GLP-1 receptor agonists and mental illness in Sweden • JAMA Psychiatry (2025) — Semaglutide and alcohol use disorder RCT Note: This episode is not medical advice. If you or a client are navigating decisions about GLP-1 medications, please consult a qualified healthcare provider.
50 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de MetaTherapy!